Sheaff Brock Investment Advisors LLC trimmed its position in shares of Masimo Corporation (NASDAQ:MASI) by 1.8% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 10,658 shares of the medical equipment provider’s stock after selling 196 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Masimo Corporation were worth $972,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in the stock. Fortaleza Asset Management Inc. purchased a new stake in shares of Masimo Corporation during the 2nd quarter valued at about $106,000. Neuburgh Advisers LLC lifted its stake in shares of Masimo Corporation by 6.4% in the 1st quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after purchasing an additional 80 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Masimo Corporation by 32.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 434 shares during the period. Glen Harbor Capital Management LLC lifted its stake in shares of Masimo Corporation by 6.4% in the 1st quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock worth $170,000 after purchasing an additional 110 shares during the period. Finally, Dubuque Bank & Trust Co. lifted its stake in shares of Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after purchasing an additional 61 shares during the period. 83.21% of the stock is currently owned by institutional investors.
In related news, COO Anand Sampath sold 40,000 shares of Masimo Corporation stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $92.00, for a total transaction of $3,680,000.00. Following the sale, the chief operating officer now directly owns 20,000 shares of the company’s stock, valued at $1,840,000. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Sanford Fitch sold 14,000 shares of Masimo Corporation stock in a transaction dated Thursday, June 29th. The stock was sold at an average price of $92.06, for a total value of $1,288,840.00. Following the sale, the director now directly owns 90,249 shares in the company, valued at $8,308,322.94. The disclosure for this sale can be found here. In the last ninety days, insiders sold 126,000 shares of company stock valued at $11,732,930. 16.60% of the stock is currently owned by insiders.
Shares of Masimo Corporation (MASI) opened at 84.91 on Friday. The stock’s 50 day moving average price is $85.78 and its 200-day moving average price is $90.95. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 13.92 and a beta of 0.84. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71.
Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The company’s revenue was up 11.8% compared to the same quarter last year. During the same period last year, the company posted $0.57 EPS. Equities analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://baseballnewssource.com/markets/masimo-corporation-masi-shares-sold-by-sheaff-brock-investment-advisors-llc/1590241.html.
A number of research firms have commented on MASI. BidaskClub raised shares of Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Stifel Nicolaus started coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price objective for the company. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th. Finally, Zacks Investment Research lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $95.00.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with our FREE daily email newsletter.